Table 3. Baseline characteristics of CV-risk patient cohorts (continuation of Table 2 ).
| CV-risk patients | DYDA | EPATH | STYRIAN VITD | STOP-HF | ASCOT | PROSPER |
| No. of patients | 937 | 40 | 286 | 481 | 19257 | 5804 |
| Women, No. (%) | 358 (38) | 32 (80.0) | 136 (48) | 264 (55) | 4515 (24) | 3000 (52) |
| Age, years | 62±8 | 69±10 | 60±11 | 67±10 | 63±9 | 75±3 |
| Body mass index, kg/m2 | 28.6±4.4 | 28.7±6.4 | 29.5±4.8 | 30.3±4.8 | 28.7±4.6 | 26.8±4.2 |
| Weight, kg | 79.5±14.6 | 75.0±16.9 | 84.7±17.6 | 85.4±16.3 | 84.6±15.5 | 73.4±13.4 |
| Height, cm | 167±10 | 162±9 | 169±9 | 168±10 | 172±9 | 165±9 |
| Smokers, No. (%) | 179 (19) | 4 (10) | 42 (14) | 36 (8) | 6277 (33) | 1558 (27) |
| Consume alcohol, No. (%) | NA | 19 (48) | 239 (84) | 298 (62) | 14294 (74) | 3228 (56) |
| Hypertension, No. (%) | 602 (64) | 24 (60) | 286 (100) | NA | 19257 (100) | 3592 (62) |
| Diabetes mellitus, No. (%) | 937 (100) | 3 (8) | 58 (20) | 145 (30) | 5145 (27) | 623 (11) |
| Heart failure, No. (%) | 0 | 4 (10) | NA | 0 | 0 | 0 |
| Systolic blood pressure, mmHg | 137±15 | 143±20 | 141±18 | 132±17 | 164±18 | 155±22 |
| Diastolic blood pressure, mmHg | 80±8 | 87±11 | 87±12 | 82±11 | 95±10 | 84±12 |
| Heart rate, beats per minute | 73±10 | 66±11 | 63±10 | 70±12 | 72±13 | NA |
| Cholesterol, mmol/L | 5.0±0.95 | 5.1±1.1 | 5.2±1.2 | 4.7±0.94 | 5.9±1.1 | 5.7±0.91 |
| Glucose, mmol/L | 8.3±2.3 | 5.5±1.2 | 6.0±1.9 | 7.1±2.7 | 6.2±2.1 | NA |
| Hemoglobin, g/dL | NA | 13.7±1.4 | 14.2±1.3 | NA | NA | NA |
| Red blood cell count, 1012 cells/L | NA | 4.6±0.44 | 4.8±0.40 | NA | NA | NA |
| White blood cell count, 109 cells/L | NA | 6.1±1.8 | 5.9±1.6 | NA | NA | NA |
| Platelets, 109 cells/L | NA | 225±64 | 234±61 | NA | NA | NA |
| Creatinine, μmol/L | 80.3±23.7 | 73.5±15.8 | 82.7±23.6 | NA | 98.7±16.8 | NA |
| BNP, pg/mL | NA | NA | NA | 24 (12–52) | NA | NA |
| NT-proBNP, pg/mL | 36 (16–69) | 112 (51–186) | 85 (45–159) | NA | NA | NA |
| Left ventricular mass, g | 172±42 | NA | NA | 178±49 | NA | NA |
| Left ventricular ejection fraction, % | 61±5 | 64±9 | NA | 67±8 | NA | NA |
| Proportion with LVEF <40% | 3 (0.44) | 1 (3) | NA | 2 (0.42) | NA | NA |
| Proportion with LVEF 40–50% | 16 (2) | 1 (3) | NA | 9 (2) | NA | NA |
| Proportion with LVEF >50% | 669 (97) | 34 (94) | NA | 465 (98) | NA | NA |
| E/A ratio | 0.89±0.24 | 0.95±0.38 | NA | 0.85±0.27 | NA | NA |
Data are reported as number (%), mean±SD or median (25th–75th) for non-normally distributed variables.
NA: data not available within the cohort